India and the US race against the July 24 tariff deadline as negotiators work to finalise a trade agreement with major implications for exporters.
NEW DELHI: The clock is ticking toward a significant trade deadline. At 12:01 am EDT on July 24, the United States’ emergency Section 122 tariff regime, a temporary 10% surcharge imposed on Indian and other global imports since February, is set to expire under its statutory 150-day limit. As of July 22 no bilateral trade agreement has been signed, no formal extension has been issued and negotiators on both sides continue describing talks as being in their final stages.
Rather than a single outcome, three distinct scenarios are now in play, each carrying meaningfully different consequences for Indian exporters across pharmaceuticals, gems, textiles and engineering goods.
Where Talks Currently Stand
Commerce Minister Piyush Goyal has firmly pushed back on recent reports suggesting India rejected a quick interim deal, calling such claims “false, baseless, and misleading.” Commerce Secretary Rajesh Agrawal has confirmed that the conceptual framework of an interim agreement is largely settled, with formal signing pending mutual agreement on timing between both governments. US Ambassador Sergio Gor similarly described the remaining gaps as the “last 1%” of legal text alignment as recently as July 11.
This suggests both sides are genuinely close, even if the exact sequencing of a signature remains uncertain heading into the deadline.
Scenario One: A Signed Deal
If the interim Bilateral Trade Agreement is executed before midnight on July 24, Indian goods entering the US would face an 18% reciprocal baseline tariff, a significant drop from the 50% penalty rates discussed in earlier negotiating rounds. Notably several strategic sectors would receive complete duty-free access, including generic pharmaceuticals, cut and polished diamonds and civil aircraft components. In exchange India would extend tariff relief on select US agricultural and industrial goods, alongside a commercial commitment to purchase $500 billion in American energy, aircraft and technology products over five years.
For India’s gems and jewellery sector, centred heavily around Surat’s diamond cutting industry, this scenario offers the clearest and most immediate benefit, eliminating tariffs that currently affect competitiveness against Vietnam and other regional rivals.
Scenario Two: A Bridging Extension
Since Section 122 cannot legally be extended beyond its 150-day cap through executive action alone, Washington could instead deploy alternative trade authorities, such as Section 301 or Section 232, to maintain the existing 10% baseline surcharge while final legal text is completed. This would effectively buy both sides additional time without disrupting current trade flows, offering a pragmatic middle path if final signatures require a few more weeks.
Scenario Three: Tariffs Simply Lapse
Should no deal or extension materialise, Section 122 tariffs would automatically expire, reverting duties to standard Most Favoured Nation rates under the US tariff schedule. Interestingly this outcome is not uniformly negative for Indian exporters. For sectors like textiles and engineering goods, MFN reversion rates, ranging between roughly 1.5% and 11.5% depending on the category, would actually undercut both the current 10% surcharge and the proposed 18% reciprocal rate under a signed deal. This gives India’s textile and engineering export bodies a somewhat counterintuitive reason to view a delayed deal without excessive concern, at least in the near term.
Pharma Stays Protected Either Way
One reassuring constant across all three scenarios is pharmaceuticals, India’s fourth-largest export category to the US at $9.6 billion annually. Generic drugs retain duty-free access under existing WTO pharmaceutical agreements regardless of which scenario unfolds, insulating this critical sector from deadline uncertainty entirely.
A Watchful Eye on Currency and Markets
Financial markets have already begun positioning for each possibility. The rupee, currently trading near 87.65 to 87.90 against the dollar, is expected to see a modest relief rally toward 87.20 if a deal is signed, while remaining broadly rangebound under an extension scenario. Even under the no-deal scenario, any rupee softening would offer a modest silver lining for India’s IT services exporters, who benefit from more favourable dollar conversion on their earnings.
A Position of Relative Strength
With total merchandise exports to the US reaching $87.3 billion last fiscal year and a healthy trade surplus of $34.4 billion, India enters this deadline from a position of considerable trade strength rather than vulnerability. Whichever scenario plays out over the coming days, India’s diversified export base across pharmaceuticals, gems, textiles and engineering goods gives it credible competitive footing under each possible outcome, a reassuring sign of the resilience built into India’s trade relationship with its largest export market.
About the Author
